Ustekinumab-Ttwe Drug Interactions: 2 Major, 1 Moderate
Ustekinumab-Ttwe Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ustekinumab-Ttwe. Always confirm against the full prescribing information.
100 interactions
Abacavir
Abacavir may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Abatacept
Abatacept may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Abemaciclib
Ustekinumab may increase the hepatotoxic activities of Abemaciclib.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Acamprosate
Acamprosate may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Acebutolol
Acebutolol may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Aceclofenac
Ustekinumab may increase the hepatotoxic activities of Aceclofenac.
Level 2 evidence
Acetaminophen
Acetaminophen may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Acetylsalicylic acid
Acetylsalicylic acid may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Ustekinumab.
Level 2 evidence
Enter your NPI to unlock 1 major interaction for Ustekinumab-Ttwe
Ustekinumab-Ttwe has 642 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ustekinumab-Ttwe has 2 major, 1 moderate, and 639 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ustekinumab-Ttwe. Always confirm against the full prescribing information.